JP5650642B2 - メチオニンアナログおよびそれらを使用する方法 - Google Patents

メチオニンアナログおよびそれらを使用する方法 Download PDF

Info

Publication number
JP5650642B2
JP5650642B2 JP2011521364A JP2011521364A JP5650642B2 JP 5650642 B2 JP5650642 B2 JP 5650642B2 JP 2011521364 A JP2011521364 A JP 2011521364A JP 2011521364 A JP2011521364 A JP 2011521364A JP 5650642 B2 JP5650642 B2 JP 5650642B2
Authority
JP
Japan
Prior art keywords
compound
alkyl
optionally substituted
pharmaceutically acceptable
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011521364A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011529921A5 (enExample
JP2011529921A (ja
Inventor
マンスール バッシィリ，
マンスール バッシィリ，
アフサネー ライミ−ラリジャーニ，
アフサネー ライミ−ラリジャーニ，
Original Assignee
バイオキシネス ファーマシューティカルズ， インコーポレイテッド
バイオキシネス ファーマシューティカルズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオキシネス ファーマシューティカルズ， インコーポレイテッド, バイオキシネス ファーマシューティカルズ， インコーポレイテッド filed Critical バイオキシネス ファーマシューティカルズ， インコーポレイテッド
Publication of JP2011529921A publication Critical patent/JP2011529921A/ja
Publication of JP2011529921A5 publication Critical patent/JP2011529921A5/ja
Application granted granted Critical
Publication of JP5650642B2 publication Critical patent/JP5650642B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/66—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2011521364A 2008-08-01 2009-07-31 メチオニンアナログおよびそれらを使用する方法 Expired - Fee Related JP5650642B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8555608P 2008-08-01 2008-08-01
US61/085,556 2008-08-01
PCT/US2009/052474 WO2010014943A2 (en) 2008-08-01 2009-07-31 Methionine analogs and methods of using same

Publications (3)

Publication Number Publication Date
JP2011529921A JP2011529921A (ja) 2011-12-15
JP2011529921A5 JP2011529921A5 (enExample) 2012-09-13
JP5650642B2 true JP5650642B2 (ja) 2015-01-07

Family

ID=41414372

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011521364A Expired - Fee Related JP5650642B2 (ja) 2008-08-01 2009-07-31 メチオニンアナログおよびそれらを使用する方法

Country Status (8)

Country Link
US (5) US8580859B2 (enExample)
EP (1) EP2326619B1 (enExample)
JP (1) JP5650642B2 (enExample)
CN (1) CN102171185A (enExample)
AU (1) AU2009276343A1 (enExample)
CA (1) CA2733390A1 (enExample)
IL (1) IL210956A0 (enExample)
WO (1) WO2010014943A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580859B2 (en) 2008-08-01 2013-11-12 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
US9200251B1 (en) 2011-03-31 2015-12-01 David Gordon Bermudes Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith
WO2019169029A1 (en) 2018-02-28 2019-09-06 Bioxiness Pharmaceuticals, Inc. Target specific chemotherapeutic agents

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR961832A (enExample) * 1943-03-20 1950-05-23
CH254537A (de) 1947-12-18 1948-05-15 Ag Sandoz Verfahren zur Herstellung eines neuen kapillaraktiven Stoffes.
DE1020144B (de) * 1956-07-02 1957-11-28 Dehydag Gmbh Wasch- und Reinigungsmittel
FR1390191A (fr) 1963-07-19 1965-02-26 Dehydag Gmbh Procédé de préparation de sulfobétaïnes à bases hétérocycliques de type aromatique
US3519683A (en) * 1967-03-31 1970-07-07 Meiji Seika Co Process for preparing 5-amino-5-deoxy-d-glucose-1-sulfonic acid
GB1580899A (en) * 1976-07-27 1980-12-10 Fujisawa Pharmaceutical Co Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof
JPS5463024A (en) 1977-10-27 1979-05-21 Fujisawa Pharmaceut Co Ltd 3-(n-formyl-n-hydroxyamino)-2(r)-hydroxypropyl-phosphonic acid, its preparation, and its use
US4169950A (en) * 1977-12-08 1979-10-02 Research Organics Amino-hydroxy-alkyl sulfonic acid zwitterions
IL61985A0 (en) 1980-02-01 1981-02-27 Sparamedica Ag Phosphinic and phosphonic acid derivatives,their manufacture and pharmaceutical compositions containing them
DE3273586D1 (en) 1981-11-02 1986-11-06 Ici Plc Substituted propyl phosphonic acid derivatives, their use as herbicides, herbicidal compositions containing them, and methods of preparing them
DE3245887A1 (de) 1982-12-11 1984-06-14 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung substituierter phosphon und phosphinsaeuren
GB8308506D0 (en) 1983-03-28 1983-05-05 Ici Plc Heterocyclic compounds
GB8410989D0 (en) 1984-04-30 1984-06-06 Ici Plc Heterocyclic compounds
DE3435156A1 (de) 1984-09-25 1986-04-03 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung der stereoisomeren von 1-amino-alkylphosphonsaeuren oder 1-aminoalkylphosphinsaeuren
JPS62215597A (ja) 1986-03-14 1987-09-22 Mitsubishi Chem Ind Ltd β−メルカプト−α−アミノエチルホスホン酸誘導体
IT1211792B (it) * 1987-09-21 1989-11-03 Sigma Tau Ind Farmaceuti O-alcanoil derivati dell'acido 3ammino-2-idrossipropansolfonico adattivita'anticonvulsivante e loro composizioni farmaceutiche per il trattamento terapeutico dell'epilessia
GB8727792D0 (en) 1987-11-27 1987-12-31 Merck Sharp & Dohme Therapeutic agents
SE8801729D0 (sv) * 1988-05-06 1988-05-06 Astra Ab Purine derivatives for use in therapy
JP2733511B2 (ja) 1988-10-22 1998-03-30 日本臓器製薬株式会社 新規アミノアルカン誘導体
JP3174566B2 (ja) 1990-04-20 2001-06-11 日本臓器製薬株式会社 アミノアルカン誘導体
EP0467856B1 (en) * 1990-07-19 1997-03-19 Nippon Zoki Pharmaceutical Co. Ltd. Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases
JP2724906B2 (ja) 1990-07-19 1998-03-09 日本臓器製薬株式会社 新規フェニルアラニルアミノアルカン誘導体
DE4124004C2 (de) 1991-07-19 1995-01-26 Hell Ag Linotype Vorrichtung zum Auf- und Abspannen von Filmmaterial und Betriebsweise der Vorrichtung
GB9122859D0 (en) * 1991-10-28 1991-12-11 Smithkline Beecham Plc Novel compounds
JPH07116382B2 (ja) 1992-01-28 1995-12-13 株式会社同仁化学研究所 水溶性メチレンビスジアルキルアニリン誘導体及びその塩類並びにそれらを用いた過酸化物質定量用組成物
GB9202779D0 (en) 1992-02-10 1992-03-25 Ici Plc Novel compounds
US5760021A (en) * 1992-05-29 1998-06-02 The Procter & Gamble Company Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
WO1994020508A1 (en) * 1993-03-08 1994-09-15 Eisai Co., Ltd. Phosphonic acid derivatives
CA2118985A1 (en) 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
EP0708079B1 (en) * 1993-07-09 1999-04-14 Kao Corporation 2-hydroxypropanediamine derivative and detergent composition containing the same
US5658749A (en) * 1994-04-05 1997-08-19 Corning Clinical Laboratories, Inc. Method for processing mycobacteria
JPH09316474A (ja) 1996-05-24 1997-12-09 Hitachi Maxell Ltd 潤滑性物質およびこの潤滑性物質を用いた磁気記録媒体
WO1998015525A1 (en) * 1996-10-07 1998-04-16 Sumitomo Pharmaceuticals Co., Ltd. Hydroxamic acids
CZ141399A3 (cs) 1996-10-24 1999-07-14 Novartis Ag Substituované aminoalkanfosfonové kyseliny, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
US6172057B1 (en) * 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
CN1265647A (zh) 1997-07-31 2000-09-06 普罗克特和甘保尔公司 无环金属蛋白酶抑制剂
US6403632B1 (en) * 2000-03-01 2002-06-11 Bristol Myers Squibb Pharma Co Lactam metalloprotease inhibitors
ZA988967B (en) 1997-10-03 2000-04-03 Du Pont Pharm Co Lactam metalloprotease inhibitors.
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
FR2780402B1 (fr) * 1998-06-30 2001-04-27 Adir Nouveaux composes acides carboxyliques et hydroxamiques inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1330661A (zh) 1998-12-10 2002-01-09 霍夫曼-拉罗奇有限公司 原胶原c端蛋白酶抑制剂
FR2788526B1 (fr) * 1999-01-20 2002-07-05 Inst Nat Sante Rech Med Composes tripeptidiques utiles a titre d'hinhibiteurs selectifs de l'aminopeptidase a et compositions pharmaceutiques correspondantes
EP1165500A1 (en) * 1999-04-02 2002-01-02 Du Pont Pharmaceuticals Company Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase
FR2791982B1 (fr) * 1999-04-06 2002-12-27 Inst Nat Sante Rech Med Inhibiteurs de lta4 hydrolase et leurs applications therapeutiques.
AU4249700A (en) * 1999-04-19 2000-11-02 Sumitomo Pharmaceuticals Company, Limited Hydroxamic acid derivative
HK1051137A1 (zh) * 1999-07-09 2003-07-25 Isis Innovation Limited 抑制疾病的化合物和製備移植用的細胞
JP4153647B2 (ja) 2000-04-05 2008-09-24 三菱重工業株式会社 フェントン反応抑制剤および一重項酸素産生抑制剤
AU2001279649A1 (en) 2000-06-08 2001-12-17 Jomaa Pharmaka Gmbh Use of organophosphorous hydroxamic acid derivatives for producing medicaments
WO2002018395A1 (en) * 2000-08-31 2002-03-07 Merck & Co., Inc. Phosphate derivatives as immunoregulatory agents
WO2002028829A2 (en) * 2000-09-25 2002-04-11 Questcor Pharmaceuticals, Inc. Peptide deformylase inhibitors
EP1361872A4 (en) 2000-10-03 2004-05-19 Univ Virginia NEW LYSOPHOSPHIC ACID RECEPTOR AGONISTS AND ANTAGONISTS
FR2816837A1 (fr) 2000-11-17 2002-05-24 Oreal Utilisation d'au moins un derive amino sulfonique dans une composition destinee a favoriser la desquamation de la peau
FR2821621B1 (fr) * 2001-03-05 2004-11-05 Oreal Polyurethannes anioniques a caractere elastique et leur utilisation dans des compositions cosmetiques
EP1469863A2 (en) * 2002-01-18 2004-10-27 Merck & Co., Inc. Selective s1p1/edg1 receptor agonists
ES2387803T3 (es) 2003-01-08 2012-10-02 Novartis Vaccines And Diagnostics, Inc. Agentes antibacterianos
DK1602660T3 (da) 2003-02-18 2011-05-23 Kyorin Seiyaku Kk Aminophosphonsyrederivater, additionssalte deraf og S1P-receptormodulatorer
AU2004249529A1 (en) 2003-06-23 2004-12-29 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases
FR2858617A1 (fr) * 2003-08-06 2005-02-11 Inst Nat Sante Rech Med Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant
US7662856B2 (en) * 2003-08-29 2010-02-16 The University Of Houston System Compositions having antimycrobial activity including a hydroxamate or a hydroxamate and a hydroxlyamine
US20050107447A1 (en) * 2003-11-03 2005-05-19 Lynch Kevin R. Novel lysophosphatidic acid receptor agonists and antagonists
JP4182910B2 (ja) 2004-03-30 2008-11-19 ダイソー株式会社 スフィンゴミエリン類縁体とその製造法
AU2005310986A1 (en) * 2004-11-12 2006-06-08 Bellus Health (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
EP1836161B1 (en) * 2004-12-22 2016-07-20 BHI Limited Partnership Methods and compositions for treating amyloid-related diseases
KR20070121644A (ko) * 2005-01-14 2007-12-27 유리젠, 인코포레이티드 하부 요로 치료용 키트 및 개선된 조성물
JP2006257069A (ja) 2005-02-17 2006-09-28 Kemikurea:Kk 蛍光標識化スフィンゴシン１−リン酸メチレン置換体およびリン酸アルケニル置換体
JP2009520695A (ja) * 2005-12-15 2009-05-28 ヴィキュロン ファーマシューティカルズ インコーポレイテッド 抗菌活性を有するｎ−ヒドロキシアミド誘導体
EP2240019A4 (en) 2007-12-03 2011-11-16 Signum Biosciences Inc MIMETIC ACID COMPOUNDS FOR INHIBITING ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE
US8580859B2 (en) 2008-08-01 2013-11-12 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same

Also Published As

Publication number Publication date
US20110196014A1 (en) 2011-08-11
AU2009276343A1 (en) 2010-02-04
IL210956A0 (en) 2011-04-28
CN102171185A (zh) 2011-08-31
US8580859B2 (en) 2013-11-12
JP2011529921A (ja) 2011-12-15
EP2326619B1 (en) 2019-02-27
CA2733390A1 (en) 2010-02-04
WO2010014943A3 (en) 2011-01-13
US20140142189A1 (en) 2014-05-22
US20150329481A1 (en) 2015-11-19
US9695119B2 (en) 2017-07-04
US20170029369A1 (en) 2017-02-02
WO2010014943A2 (en) 2010-02-04
US20170267632A1 (en) 2017-09-21
EP2326619A2 (en) 2011-06-01

Similar Documents

Publication Publication Date Title
JP5564264B2 (ja) Ｎ−ハロゲン化アミノ化合物および誘導体
KR101057609B1 (ko) Ｎ,ｎ-디할로겐화 아미노산 및 유도체
JP7041166B2 (ja) トリアリールポリアミンを含む組成物および方法
KR20070098947A (ko) 하이포할로우스 산과의 조합의 ｎ-할로겐화 아미노산 및ｎ,ｎ-디할로겐화 아미노산
EP0312000A1 (en) Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
KR20010034861A (ko) 항박테리아제로서의 히드록삼산 유도체
WO2013040527A1 (en) Antimicrobial compounds
US20170267632A1 (en) Methionine analogs and methods of using same
JP2005515263A6 (ja) 新規な置換アルカン化合物及びその使用法
JP2005515263A (ja) 新規な置換アルカン化合物及びその使用法
JP2014513670A (ja) 抗生物質又は防腐剤処理におけるポリアミノイソプレニル誘導体の使用
JP4109123B2 (ja) ペプチドデホルミラーゼ活性化プロドラッグ
WO2013040526A1 (en) Antimicrobial compounds
US20070135353A1 (en) Crystalline n-formyl hydroxylamine compounds
MXPA04010230A (es) Profarmacos de peptido deformilasa activada.
JP2002161041A (ja) 感染症治療剤
KR20080080176A (ko) 디페닐 유레아 유도체
ZA200604768B (en) Disinfecting composition and methods of making and using same
CN117886808A (zh) 一种1,3,4-噻二唑类肽脱甲酰基酶酶抑制剂及其制备与应用
JPS62129217A (ja) 医薬用殺菌組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120727

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120727

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20131219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131227

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140306

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140313

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140627

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141031

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141113

R150 Certificate of patent or registration of utility model

Ref document number: 5650642

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees